Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. M.S. (Mathieu) Bolhuis

Publicaties

Reply to 'Therapeutic drug monitoring for isoniazid and rifampicin exposure'

Repurposing empagliflozin in individuals with glycogen storage disease Ib: A value-based healthcare approach and systematic benefit-risk assessment

Bedaquiline exposure in people with drug-resistant TB treated for diabetes: analysis of two phase 2 trials

Clinical standards for the management of adverse effects during treatment for TB

Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment

Isoniazid and rifampicin exposure during treatment in drug-susceptible TB

Clinical relevance of rifampicin-moxifloxacin interaction in isoniazid resistant/intolerant tuberculosis patients

Clinical standards for drug-susceptible pulmonary TB

Combining digital adherence technology and therapeutic drug monitoring for personalised TB care

Lees meer